Home » Ocular Therapeutix Grabs $14 Million in New Round for Eye Therapies
Ocular Therapeutix Grabs $14 Million in New Round for Eye Therapies
Ocular Therapeutix has found a new investor and a fresh round of capital to advance its hydrogel-based treatments for the eye, CEO Amar Sawhney said.
Xconomy
Xconomy
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May